September 26, 2018
FOR IMMEDIATE RELEASE
(Pittsburgh, Pennsylvania). The Amistad Law Project, The Abolitionist Law Center, and the Law Office of Carey Shenkman on Monday filed a lawsuit in the United States District Court for the Middle District of Pennsylvania to compel the Pennsylvania Department of Corrections (DOC) to treat Lester Eaddy for Hepatitis C. Since 2012, Lester Eaddy, housed at SCI Mahanoy, has unsuccessfully petitioned the Pennsylvania Department of Corrections to treat his medical condition, even though the DOC has known about his Hepatitis C diagnosis for over two decades.
At issue is the refusal of the DOC to give Mr. Eaddy Direct Acting Anti-Viral drugs (“DAAs”) to cure his Hepatitis C. The DAA medication is known to have a 90% success rate in treating individuals who suffer from chronic Hepatitis C, but the DOC denies providing potentially life-saving DAAs in favor of a costly and burdensome monitoring program. Mr. Eaddy’s illness is exacerbated by the fact he also suffers from diabetes, anemia, and kidney disease which means the denial of medical care not only subjects him to irreversible harm but also places him at risk of death.
Morally and legally, the DOC is failing in its job to ensure Mr. Eaddy receives appropriate medical care. We demand he receive DAA treatment immediately.
While there are over 5,000 incarcerated persons who have Hepatitis C, the DOC ceased treating incarcerated persons in 2013, when DAA medications became readily available. The DOC instead created a treatment protocol to limit incarcerated persons access to DAA medications despite the epidemic levels of diagnosis. This protocol was found to be “a conscious disregard of a known risk of advanced cirrhosis and death…” and ruled unconstitutional in 2017. The DOC refuses to treat Hepatitis C patients with DAA medication instead chooses to ration care to preserve their bottom line risking lives such as Mr. Eaddy’s in the process. Moreover, the DOC protocol falls below the recommendations set forth by the American Association for the Study of Liver Diseases (AASLD) and supported by the Center for Disease Control (CDC).
Plaintiffs submitted an expert report from Dr. Stacey Beth Trookin , who sits on the Treatment Guidance Panel for the AASLD and the Infectious Diseases Society of America (IDSA), finding the current DOC protocol is substandard care that is medically indefensible. Additionally, she found the DAA treatments are cost effective and medically necessary as a matter of public health, especially when the individuals are suffering from other illnesses such as diabetes.
Even though Lester Eaddy’s preexisting medical conditions put him at a Priority level 3, signaling the necessity of the treatment, he has yet to receive the DAA medications. Since the DOC continuously fails to live up to the recommended standard of care and treat individual with the DAA treatments by ignoring Mr. Eaddy’s repeated request for medical care, this lawsuit seeks a preliminary injunction to ensure Lester Eaddy receives the DAA treatment.
Bret Grote, Abolitionist Law Center, email@example.com, 412-654-9070